Stock Quote        
  Join        Login  
logo

Hologic to Participate in Four Investor Conferences

Thursday, May 10, 2012 8:00 AM

BEDFORD, Mass., May 10, 2012 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that company management will participate in the following investor conferences:

  • Rob Cascella, President and Chief Executive Officer, will present at:
    • The Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas, Nevada on Tuesday, May 15, 2012 at 7:20p.m. (Eastern Time).
    • The Goldman Sachs 33rd Annual Global Healthcare Conference in Rancho Palos Verdes, California on Wednesday, June 6, 2012 at 2:20p.m. (Eastern Time).
    • The William Blair 32nd Annual Growth Stock Conference in Chicago, Illinois on Wednesday, June 13, 2012 at 3:00pm (Eastern Time).


  • Glenn Muir, Executive Vice President and Chief Financial Officer, will present at:
    • The Jefferies 2012 Global Healthcare Conference in New York City, New York on Tuesday, June 5, 2012 at 9:30a.m. (Eastern Time).

Interested parties are invited to listen to the live audio webcasts of the investor presentations on the investor section of Hologic's website at www.hologic.com/investors-overview. Archives of the presentations will be available for replay following the conferences.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast Magnetic Resonance Imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.

Contact:

Deborah Gordon


Vice President, Investor Relations


Hologic, Inc.


(781) 999-7716

 

SOURCE Hologic, Inc.

(Source: PR Newswire )
(Source: Quotemedia)

Follow iStockAnalyst on Twitter Follow iStockAnalyst on Twitter
Subscribe to Email Alerts
Advertisement
Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 




Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.